<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02076334</url>
  </required_header>
  <id_info>
    <org_study_id>13-3101</org_study_id>
    <nct_id>NCT02076334</nct_id>
  </id_info>
  <brief_title>Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise</brief_title>
  <official_title>Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rhodia, Inc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine the influence of compression garments manufactured with Far-Infrared technology on
      exercise performance during and after repeated eccentric isokinetic muscle actions of the leg
      extensors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants: Eighty recreationally active (1-5 hrs per week) healthy participants between
      the ages of 18 - 35 will visit the Neuromuscular Research Laboratory on 6 separate occasions,
      with 4 of those occasions also requiring a visit to Health services for a blood draw.

      Procedures (methods): During pre-screening, each participant will complete an informed
      consent document, a health history questionnaire, and have their stature and body mass
      assessed. A familiarization session will then be conducted on a separate day where all
      participants will practice the strength assessment, eccentric isokinetic protocol, and
      ultrasound assessments. Participants will be assigned to 1 of the 4 treatment groups based on
      their initial maximal isometric strength values using a matched-participants design. The
      first experimental session will then begin 2-10 days later, where the participants will
      perform the repeated eccentric exercise protocol (10 sets of 15 eccentric contractions 210
      deg/sec with 3 min of rest between sets) with the non-dominant leg following a 60 min rest
      period where they will wear the apparel and perform a 5 min warm-up on a cycle ergometer.
      Follow-up blood draws and strength and ultrasound assessments will be obtained at 24 and 48
      hours post-exercise. Each participant will also complete a visual analog scale at baseline,
      24, 48, and 72 hours post-exercise to examine perceived muscle soreness.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal Voluntary Contraction (MVC)</measure>
    <time_frame>up to 72 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Creatine Kinase</measure>
    <time_frame>baseline, 24 hrs and 48 hrs post</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Muscle Damage</condition>
  <arm_group>
    <arm_group_label>Compression + normal garment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Far Infrared Fabric during exercise + Spandex at night</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Garment + Test garment at night</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spandex during exercise + Far Infrared Fabric at night</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Garment + normal garment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Spandex during exercise + Spandex at night</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test garment + Test garment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Far Infrared Fabric during exercise + Far Infrared Fabric at night</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Far Infrared Fabric</intervention_name>
    <arm_group_label>Compression + normal garment</arm_group_label>
    <arm_group_label>Normal Garment + Test garment at night</arm_group_label>
    <arm_group_label>Test garment + Test garment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Spandex</intervention_name>
    <arm_group_label>Compression + normal garment</arm_group_label>
    <arm_group_label>Normal Garment + Test garment at night</arm_group_label>
    <arm_group_label>Normal Garment + normal garment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cohort of Adult Males &amp; Females

          -  Participant is between the ages of 18-35

          -  Healthy, Recreationally Active (1-5 hours per week)

          -  Participant has provided written and dated informed consent to participate in the
             study

          -  Participant is apparently healthy and free from disease, as determined by a health
             history questionnaire

          -  Participant agrees to abstain from smoking, caffeine (4hrs prior), tobacco (24hrs
             prior), and alcohol (24 hrs) before testing days

          -  Participant agrees to abstain from exercise 24 hours prior to each testing visit and
             after 72 hours of the induced exercise damage

          -  Participant will refrain from the use of non-steroidal anti-inflammatory drugs
             (NSAIDs) and protein supplementation 24 hours before the exercise testing protocol, as
             well as for the 72 hour period following the exercise testing protocol.

        Exclusion Criteria:

          -  Participant is using, or has used one of the following dietary supplements within 12
             weeks prior to enrollment: beta-alanine, creatine, taurine, or any supplemental
             antioxidants (Acai, pomegranate, beet juice).

          -  Participant is in, or has participated in another clinical trial within 6 weeks prior
             to enrollment

          -  Participant has a known allergy or sensitivity to test product (determined from health
             history questionnaire and consent form)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abbie Smith-Ryan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Exercise and Sport Science (University of North Carolina)</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/19222900</url>
  </link>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2014</study_first_submitted>
  <study_first_submitted_qc>February 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2014</study_first_posted>
  <results_first_submitted>January 19, 2017</results_first_submitted>
  <results_first_submitted_qc>April 13, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 11, 2017</results_first_posted>
  <last_update_submitted>April 13, 2017</last_update_submitted>
  <last_update_submitted_qc>April 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>compression, isokinetic, far-infrared</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Compression + Normal Garment</title>
          <description>Far Infrared Fabric during exercise + Spandex at night
Far Infrared Fabric
Spandex</description>
        </group>
        <group group_id="P2">
          <title>Normal Garment + Test Garment at Night</title>
          <description>Spandex during exercise + Far Infrared Fabric at night
Far Infrared Fabric
Spandex</description>
        </group>
        <group group_id="P3">
          <title>Normal Garment + Normal Garment</title>
          <description>Spandex during exercise + Spandex at night
Spandex</description>
        </group>
        <group group_id="P4">
          <title>Test Garment + Test Garment</title>
          <description>Far Infrared Fabric during exercise + Far Infrared Fabric at night
Far Infrared Fabric</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="21"/>
                <participants group_id="P4" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>muscle soreness</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Compression + Normal Garment</title>
          <description>Far Infrared Fabric during exercise + Spandex at night
Far Infrared Fabric
Spandex</description>
        </group>
        <group group_id="B2">
          <title>Normal Garment + Test Garment at Night</title>
          <description>Spandex during exercise + Far Infrared Fabric at night
Far Infrared Fabric
Spandex</description>
        </group>
        <group group_id="B3">
          <title>Normal Garment + Normal Garment</title>
          <description>Spandex during exercise + Spandex at night
Spandex</description>
        </group>
        <group group_id="B4">
          <title>Test Garment + Test Garment</title>
          <description>Far Infrared Fabric during exercise + Far Infrared Fabric at night
Far Infrared Fabric</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="20"/>
            <count group_id="B5" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20.5" spread="1.4"/>
                    <measurement group_id="B2" value="20.9" spread="2.0"/>
                    <measurement group_id="B3" value="22.1" spread="3.2"/>
                    <measurement group_id="B4" value="21.0" spread="2.5"/>
                    <measurement group_id="B5" value="21" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Maximal Voluntary Contraction (MVC)</title>
        <time_frame>up to 72 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Compression + Normal Garment</title>
            <description>Far Infrared Fabric during exercise + Spandex at night
Far Infrared Fabric
Spandex</description>
          </group>
          <group group_id="O2">
            <title>Normal Garment + Test Garment at Night</title>
            <description>Spandex during exercise + Far Infrared Fabric at night
Far Infrared Fabric
Spandex</description>
          </group>
          <group group_id="O3">
            <title>Normal Garment + Normal Garment</title>
            <description>Spandex during exercise + Spandex at night
Spandex</description>
          </group>
          <group group_id="O4">
            <title>Test Garment + Test Garment</title>
            <description>Far Infrared Fabric during exercise + Far Infrared Fabric at night
Far Infrared Fabric</description>
          </group>
        </group_list>
        <measure>
          <title>Maximal Voluntary Contraction (MVC)</title>
          <units>Newton-meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="182.4" spread="45.7"/>
                    <measurement group_id="O2" value="198.7" spread="56.2"/>
                    <measurement group_id="O3" value="208" spread="70.5"/>
                    <measurement group_id="O4" value="186.4" spread="44.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Creatine Kinase</title>
        <time_frame>baseline, 24 hrs and 48 hrs post</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Compression + Normal Garment</title>
            <description>Far Infrared Fabric during exercise + Spandex at night
Far Infrared Fabric
Spandex</description>
          </group>
          <group group_id="O2">
            <title>Normal Garment + Test Garment at Night</title>
            <description>Spandex during exercise + Far Infrared Fabric at night
Far Infrared Fabric
Spandex</description>
          </group>
          <group group_id="O3">
            <title>Normal Garment + Normal Garment</title>
            <description>Spandex during exercise + Spandex at night
Spandex</description>
          </group>
          <group group_id="O4">
            <title>Test Garment + Test Garment</title>
            <description>Far Infrared Fabric during exercise + Far Infrared Fabric at night
Far Infrared Fabric</description>
          </group>
        </group_list>
        <measure>
          <title>Creatine Kinase</title>
          <units>u/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140.6" spread="40.4"/>
                    <measurement group_id="O2" value="158.2" spread="41.5"/>
                    <measurement group_id="O3" value="181.2" spread="40.4"/>
                    <measurement group_id="O4" value="108.2" spread="41.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 H post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="277.1" spread="102.6"/>
                    <measurement group_id="O2" value="458.5" spread="105.2"/>
                    <measurement group_id="O3" value="516.2" spread="102.6"/>
                    <measurement group_id="O4" value="332.8" spread="105.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48 H post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="225.8" spread="127.3"/>
                    <measurement group_id="O2" value="355.8" spread="130.6"/>
                    <measurement group_id="O3" value="542.9" spread="127.3"/>
                    <measurement group_id="O4" value="263.6" spread="130.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Duration of study enrollment (3 weeks)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Compression + Normal Garment</title>
          <description>Far Infrared Fabric during exercise + Spandex at night
Far Infrared Fabric
Spandex</description>
        </group>
        <group group_id="E2">
          <title>Normal Garment + Test Garment at Night</title>
          <description>Spandex during exercise + Far Infrared Fabric at night
Far Infrared Fabric
Spandex</description>
        </group>
        <group group_id="E3">
          <title>Normal Garment + Normal Garment</title>
          <description>Spandex during exercise + Spandex at night
Spandex</description>
        </group>
        <group group_id="E4">
          <title>Test Garment + Test Garment</title>
          <description>Far Infrared Fabric during exercise + Far Infrared Fabric at night
Far Infrared Fabric</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Abbie Smith-Ryan, PhD</name_or_title>
      <organization>University University Chapel Hill</organization>
      <phone>919-962-2574</phone>
      <email>abbsmith@email.unc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

